A Biotech Breakdown and Two Sides of the Streaming Wars
CNBC's "Fast Money"
00:00
I B B Is Still Up, but It's Less Than Three % at This Point.
i b b is still up, only it's less than three % at this point. I think over the next number of years, you're going to see a massive change in molecular medicine and all these other areas. The stocks are so specific that it's hard to have a great handle on every single one of them. It's not an easy trade. You really have to understand these stories. And gve to understand clinical trials and different drugs, you know, outcomes and things like that.
Play episode from 02:04
Transcript
